324 results
Page 4 of 17
S-3ASR
fkrnqmjbrbnajo
28 May 21
Automatic shelf registration
4:19pm
8-K
EX-10.1
48ps7 senqnwu
25 May 21
Entry into a Material Definitive Agreement
9:04am
8-K
EX-99.1
qymvj51niqo9d7w2
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.1
g9q5nvx4n6ypf0sjqha
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.1
1v6jc 0zuex4
10 May 21
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
1wkdehgr
24 Feb 21
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
lcqfqdthxtxakg3eohf2
21 Jan 21
Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery
8:40am
8-K
EX-99.1
0dofamg
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.2
uu3wi4qla6xucgtm3 c5
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.1
m5ms iomi
13 Nov 20
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
8:40am
8-K
EX-99.1
p66xh9zrlfl8rot2fsd
5 Nov 20
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
bvlv18bg ikvt
28 Sep 20
Heron Therapeutics Receives European Commission Authorization for ZYNRELEFTM (HTX-011) for the Treatment of Postoperative Pain
8:41am
8-K
EX-99.1
gq8jb5qce9ixw r4a65
16 Sep 20
Regulation FD Disclosure
8:40am
8-K
EX-99.1
30p9pm10am4
8 Sep 20
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
8:41am
8-K
EX-99.1
gnj407s9
5 Aug 20
Results of Operations and Financial Condition
4:10pm